-
1 Comment
Republic Healthcare Limited is currently in a long term downtrend where the price is trading 26.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Republic Healthcare Limited's total revenue rose by 11.6% to $4M since the same quarter in the previous year.
Its net income has increased by 60.1% to $-253K since the same quarter in the previous year.
Finally, its free cash flow fell by 71.1% to $771K since the same quarter in the previous year.
Based on the above factors, Republic Healthcare Limited gets an overall score of 3/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| ISIN | KYG7516A1022 |
| Market Cap | 74M |
|---|---|
| PE Ratio | None |
| Beta | 1.39 |
| Target Price | None |
| Dividend Yield | None |
Republic Healthcare Limited, an investment holding company, operates a network of general practice medical clinics under the Dr. Tan & Partners (DTAP) brand in Singapore and the People's Republic of China. It operates through Medical Services and Education Services segments. The company offers consultation, medical investigation, and treatment; men's, women's, and sexual health; health management; management advisory; and healthcare-related education and educational support services. It also provides its services under the S Aesthetics Clinic (SAC) and California Metropolitan University (CMU) brands. Republic Healthcare Limited was founded in 2010 and is headquartered in Singapore.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 8357.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026